Henan Dongtai Pharm was founded in 2002 .The company is mainly engaged in research, production and marketing of pharmaceutical APIs and intermediates.Our main products are Dicofenac Sodium, Diclofenac Potasssium, Aceclofenac, Celecoxib, Acemetacin and Rimantadine Hydrochloride. We have exported to many countries and areas such as North America, South America, Europe, Japan, South Korea, South-east Asia and so on.
more >
Year of Establishment:
2002
Total Assets(USD):
500,000 to 99,999,999
Total Number of Staff:
100-500
Main Competitive Advantages:
Experienced R&D Staff,Production Capacity,Large Product Line,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
Main Sales Markets:
North America,Western Europe,Asia,Middle East
Other Competitive Advantages:
Patents and Copyrights: